# Relationship of Tumor Radiation–absorbed Dose to Survival and Response in Hepatocellular Carcinoma Treated with Transarterial Radioembolization with <sup>90</sup>Y in the SARAH Study

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/relationship-of-tumor-radiation-absorbed-dose-to-survival-and-response-in/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Anne-Laure Hermann,Arnaud Dieudonné,Maxime Ronot,Manuel Sánchez-García,Héléna Pereira,Gilles Châtellier,Étienne Garin,Laurent Castéra,Rachida Lebtahi,Valérie Vilgrain,For the SARAH Trial Group |
| Citations | 201 |
| DOI | 10.1148/radiol.2020191606 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W3040084298 |
| PMID | 32602828 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Maxime Ronot](https://scholariq.org/researchers/maxime-ronot/)

## Paper primary topic

- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)

## Paper topics

- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)
- [Renal cell carcinoma treatment](https://scholariq.org/topics/renal-cell-carcinoma-treatment/)
- [Radiopharmaceutical Chemistry and Applications](https://scholariq.org/topics/radiopharmaceutical-chemistry-and-applications/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.